Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITION FOR INHIBITING THE EXPRESSION OF TARGET GENE
Document Type and Number:
WIPO Patent Application WO/2011/007795
Kind Code:
A1
Abstract:
Disclosed are: a composition comprising a double-stranded nucleic acid molecule and a liposome in which the double-stranded nucleic acid molecule is encapsulated; and others. In the composition, the double-stranded nucleic acid molecule comprises an antisense strand and a sense strand, wherein the antisense strand is a polynucleotide which contains a nucleotide sequence complementary to a sequence composed of contiguous 17 nucleotides contained in mRNA for a target gene and which has a length of 17 to 30 nucleotides, the sense strand is a polynucleotide which contains a nucleotide sequence complementary to a sequence lying between the 1st nucleotide and the 17th nucleotide numbered from the 5'-terminal toward the 3'-terminal in the antisense strand and which has a length of 17 to 30 nucleotides, each of sugars respectively bound to a nucleotide located at a specific position in the antisense strand and a nucleotide located at a specific position in the sense strand is a deoxyribose or a ribose in which a hydroxy group at position-2' is substituted by a modifying group, and the deoxyribose and the ribose are contained at a specific ratio. In the composition, the liposome has a lipid bilayer membrane comprising a lipid derivative, fatty acid derivative or aliphatic hydrocarbon derivative of a water-soluble substance as a component.

Inventors:
SHINOHARA FUMIKAZU
YOSHIDA TETSUO
SUGISHITA HIROKO
NAOI TOMOYUKI
ISHII TOSHIHIKO
ENOKIZONO JUNICHI
Application Number:
PCT/JP2010/061884
Publication Date:
January 20, 2011
Filing Date:
July 14, 2010
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KYOWA HAKKO KIRIN CO LTD (JP)
SHINOHARA FUMIKAZU
YOSHIDA TETSUO
SUGISHITA HIROKO
NAOI TOMOYUKI
ISHII TOSHIHIKO
ENOKIZONO JUNICHI
International Classes:
A61K31/713; A61K9/127; A61K47/16; A61K47/18; A61K47/24; A61K47/34; A61P29/00; A61P35/00; C12N15/09
Domestic Patent References:
WO2006080118A12006-08-03
WO2010013815A12010-02-04
Foreign References:
JP2009513151A2009-04-02
Other References:
JUDGE, A.D. ET AL.: "Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice", J CLIN INVEST, vol. 119, no. 3, March 2009 (2009-03-01), pages 661 - 73, XP002618489, DOI: doi:10.1172/JCI37515
ALLERSON, C.R. ET AL.: "Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA", J MED CHEM, vol. 48, no. 4, 2005, pages 901 - 4, XP002404763, DOI: doi:10.1021/jm049167j
LAYZER, J.M. ET AL.: "In vivo activity of nuclease-resistant siRNAs", RNA, vol. 10, no. 5, 2004, pages 766 - 71, XP002598150, DOI: doi:10.1261/RNA.5239604
CHIU, Y.L. ET AL.: "siRNA function in RNAi: a chemical modification analysis", RNA, vol. 9, no. 9, 2003, pages 1034 - 48, XP008158876, DOI: doi:10.1261/rna.5103703
Download PDF: